Filed before 2025Filed 28 October 2022
Astrocyte Pharmaceuticals Inc. raised $2.84M
Astrocyte Pharmaceuticals Inc., a pharmaceuticals company based in Groton, CT, raised $2.84M in a new debt round, according to a filing dated 28 October 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 28 October 2022
- Round
- Debt round
- Amount sold
- $2.84M
- Offering size
- $5M
- Investors so far
- 48
- Based in
- Groton, CT
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 20% of the 1,764 tracked raises with an amount filed in 2022, and than 13% of the 38 in pharmaceuticals.
Astrocyte Pharmaceuticals Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 28 Oct 2022 | New filing | $2.84M | This raise |
| 10 Dec 2020 | New filing | $7.52M | Another raise |
More with Depth Ventures on the board
- Magnendo Corp.$18M
- Xeno Biosciences Inc.$1.5M
- First Light Biosciences Inc.$1.79M
- ReDigi Inc.$975K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.